HOME ·

GENSCRIPT BIO

Implementation of the Pharmaceutical Industry Development “15th Five-Year Plan” and Standout Data for Domestic Novel Drugs at WCLC: Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rose 10.82%
Tags：
Hang Seng Biotechnology Technology ETFWuXi AppTecGENSCRIPT BIO15th Five-Year Plan
2026-09-21
Going Global Weekly: Mainland Companies Flock to Hong Kong Listings, Pharma Globalisation Shifts to Data and Capability Export-20260918
Tags：
Going Global WeeklyTIME INTERCONGENSCRIPT BIO
2026-09-18
GENSCRIPT BIO (01548.HK): Partners with Lilly's TuneLab Platform to Provide Wet-lab Services
Tags：
NewTimeSpaceGENSCRIPT BIO01548.HKstrategic cooperation
2026-09-18
GENSCRIPT BIO (01548.HK) plans to issue in total 77.13 million shares by placement, with estimated net proceeds of HKD 2.33 billion
Tags：
GENSCRIPT BIO01548.HKNewTimeSpace
2026-09-11
GENSCRIPT BIO (01548.HK): Places 77.126 Million New Shares at HKD 30.50 to Raise About HKD 2.327 Billion
Tags：
GENSCRIPT BIO01548.HKPlacing
2026-09-11
GENSCRIPT BIO (01548.HK): Proposes spin-off and separate listing of Probio Technology on the Main Board
Tags：
GENSCRIPT BIO01548.HKSeparate Listing
2026-09-04
GENSCRIPT BIO(01548.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of USD 129.34 million, loss widened by 407.98% YoY
Tags：
GENSCRIPT BIO01548.HKNewTimeSpace
2026-08-17
GENSCRIPT BIO(01548.HK): Legend Biotech Reports Positive Proof-of-Concept Clinical Data for In-vivo CD19/CD20 Dual-Target CAR-T Therapy LB2501
Tags：
GENSCRIPT BIO01548.HKClinical Data
2026-06-14